ValiRx plc (LON:VAL – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 0.27 and traded as low as GBX 0.15. ValiRx shares last traded at GBX 0.15, with a volume of 455,555 shares traded.
ValiRx Price Performance
The company has a market capitalization of £2.01 million, a P/E ratio of -0.28 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 4.62 and a debt-to-equity ratio of 0.05. The business has a 50 day simple moving average of GBX 0.18 and a 200-day simple moving average of GBX 0.27.
ValiRx (LON:VAL – Get Free Report) last released its quarterly earnings results on Monday, June 22nd. The company reported GBX (0.54) EPS for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%.The firm had revenue of GBX 3 million for the quarter. Analysts predict that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
